Literature DB >> 33731882

A survey of cancer genome signatures identifies genes connected to distinct chromosomal instability phenotypes.

Manar S Shafat1,2, Eamaan S Rufaie2,3, Johnathan Watkins4.   

Abstract

Certain breast and ovarian cancers are characterised by high levels of chromosomal instability. We established a suite of eleven SNP array-based signatures of various forms of chromosomal instability. To understand what biological mechanisms might underpin these signatures, we generated and assembled genetic-feature data including allele-specific expression, fusion genes, gene expression, methylation, somatic coding mutations and protein expression. For each signature, we extracted a compendium of significantly associated genetic features using machine learning. We established an association between subchromosomal allelic imbalance-based measures and DNA repair genes. Numerical chromosomal instability and chromothripsis were found to have distinct genetic associations but shared a relationship to mitotic processes, while whole-genome doubling was characterised by TP53 mutation, and high AURKA and GINS1 expression. Furthermore, we identified two genetically distinct forms of tandem duplicator phenotypes. These findings identify potentially novel genomic targets for validation and drug development for specific subsets of breast and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33731882     DOI: 10.1038/s41397-021-00217-9

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  39 in total

1.  Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy.

Authors:  Courtney H Coschi; Charles A Ishak; David Gallo; Aren Marshall; Srikanth Talluri; Jianxin Wang; Matthew J Cecchini; Alison L Martens; Vanessa Percy; Ian Welch; Paul C Boutros; Grant W Brown; Frederick A Dick
Journal:  Cancer Discov       Date:  2014-04-16       Impact factor: 39.397

2.  Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors.

Authors:  Alain D Silk; Lauren M Zasadil; Andrew J Holland; Benjamin Vitre; Don W Cleveland; Beth A Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-16       Impact factor: 11.205

3.  Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.

Authors:  Nicolai J Birkbak; Zhigang C Wang; Daniel P Silver; Zoltan Szallasi; Andrea L Richardson; Ji-Young Kim; Aron C Eklund; Qiyuan Li; Ruiyang Tian; Christian Bowman-Colin; Yang Li; April Greene-Colozzi; J Dirk Iglehart; Nadine Tung; Paula D Ryan; Judy E Garber
Journal:  Cancer Discov       Date:  2012-03-22       Impact factor: 39.397

4.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

5.  Pan-cancer patterns of somatic copy number alteration.

Authors:  Travis I Zack; Stephen E Schumacher; Scott L Carter; Andre D Cherniack; Gordon Saksena; Barbara Tabak; Michael S Lawrence; Cheng-Zhong Zhsng; Jeremiah Wala; Craig H Mermel; Carrie Sougnez; Stacey B Gabriel; Bryan Hernandez; Hui Shen; Peter W Laird; Gad Getz; Matthew Meyerson; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

6.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

7.  Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch.

Authors:  H Scheerens; A Malong; K Bassett; Z Boyd; V Gupta; J Harris; C Mesick; S Simnett; H Stevens; H Gilbert; P Risser; R Kalamegham; J Jordan; J Engel; S Chen; L Essioux; J A Williams
Journal:  Clin Transl Sci       Date:  2017-02-27       Impact factor: 4.689

8.  Replication stress links structural and numerical cancer chromosomal instability.

Authors:  Rebecca A Burrell; Sarah E McClelland; David Endesfelder; Petra Groth; Marie-Christine Weller; Nadeem Shaikh; Enric Domingo; Nnennaya Kanu; Sally M Dewhurst; Eva Gronroos; Su Kit Chew; Andrew J Rowan; Arne Schenk; Michal Sheffer; Michael Howell; Maik Kschischo; Axel Behrens; Thomas Helleday; Jiri Bartek; Ian P Tomlinson; Charles Swanton
Journal:  Nature       Date:  2013-02-28       Impact factor: 49.962

Review 9.  Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers.

Authors:  Johnathan A Watkins; Sheeba Irshad; Anita Grigoriadis; Andrew N J Tutt
Journal:  Breast Cancer Res       Date:  2014-06-03       Impact factor: 6.466

10.  Substantial contribution of extrinsic risk factors to cancer development.

Authors:  Song Wu; Scott Powers; Wei Zhu; Yusuf A Hannun
Journal:  Nature       Date:  2015-12-16       Impact factor: 49.962

View more
  1 in total

Review 1.  Recent advances in targeted drug delivery systems for resistant colorectal cancer.

Authors:  Masoumeh Sharifi-Azad; Marziyeh Fathi; William C Cho; Abolfazl Barzegari; Hamed Dadashi; Mehdi Dadashpour; Rana Jahanban-Esfahlan
Journal:  Cancer Cell Int       Date:  2022-05-19       Impact factor: 6.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.